ICU Medical
ICUI
270 hedge funds and large institutions have $4.88B invested in ICU Medical in 2019 Q2 according to their latest regulatory filings, with 28 funds opening new positions, 95 increasing their positions, 99 reducing their positions, and 47 closing their positions.
160% more call options, than puts
Call options by funds: $29.6M | Put options by funds: $11.4M
67% more funds holding in top 10
Funds holding in top 10: 3 → 5 (+2)
10% more capital invested
Capital invested by funds: $4.45B → $4.88B (+$435M)
3.27% more ownership
Funds ownership: 91.47% → 94.74% (+3.3%)
4% less repeat investments, than reductions
Existing positions increased: 95 | Existing positions reduced: 99
8% less funds holding
Funds holding: 292 → 270 (-22)
40% less first-time investments, than exits
New positions opened: 28 | Existing positions closed: 47
Top Buyers
| 1 |
T. Rowe Price Associates
Baltimore,
Maryland
|
+$148M |
| 2 |
FPP
Findlay Park Partners
London,
United Kingdom
|
+$69.5M |
| 3 |
NC
Nitorum Capital
New York
|
+$52.8M |
| 4 |
Janus Henderson Group
London,
United Kingdom
|
+$32.5M |
| 5 |
Wells Fargo
San Francisco,
California
|
+$28.5M |
Top Sellers
ICUI Hedge Fund Activity: Q2 2019 in Review
270 of the 4,604 institutional investors tracked by Wall St. Rank reported a position in ICU Medical (ICUI) for Q2 2019, worth a combined $4.88B — up 9.8% from $4.45B a quarter earlier.
Sellers outnumbered buyers: 47 funds closed out of ICUI and 28 opened new positions — a net loss of 19 holders — while 99 trimmed existing stakes and 95 added.
The largest buyer was T. Rowe Price Associates, adding an estimated $148M. The largest seller was VOYA Investment Management, cutting an estimated $50.5M.
- 270 institutional investors held ICU Medical (ICUI) as of Q2 2019, down from 292 in Q1 2019.
- Funds reported $4.88B of ICU Medical stock for Q2 2019, up 9.8% quarter-over-quarter.
- 28 funds opened new ICU Medical positions in Q2 2019 and 47 closed out, a net change of -19 holders.
- The largest ICU Medical buyer in Q2 2019 was T. Rowe Price Associates, an estimated $148M added.
- The largest ICU Medical seller in Q2 2019 was VOYA Investment Management, an estimated $50.5M sold.
Based on aggregated 13F filings for Q2 2019.